Home/ Supplements/ Electrolytes/ Avocado300 Soy Unsaponifiables with Sier...

Avocado300 Soy Unsaponifiables with SierraSil - 600 mg

product on market Tablet or Pill Maximize Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Avocado soy unsaponifiables and calcium are used to support joint health and bone density, though clinical evidence for this specific combination is limited. SierraSil provides stabilized silica intended for connective tissue support. The ingredient profile maintains a high safety score, indicating a low risk of adverse effects.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Avocado300 Soy Unsaponifiables with SierraSil - 600 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
168 mg (17% DV)
Market median: 60.0mg (94 products) 13 studies (A:0, B:7)
SierraSil
800 mg

Other Ingredients

Microcrystalline Cellulose Maltodextrin Croscarmellose Sodium Silicon Dioxide Stearic Acid Hydroxypropylmethylcellulose Hydroxypropyl Cellulose Magnesium Stearate Polyethylene Glycol
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Take two (2) tablets up to three times per day.

Warnings & Precautions

Keep out of reach of children!

Do not use if safety seal is broken or missing.

Warning: Consult a physician before using this or any product, if you are pregnant, lactating, or have any medical condition.

Contains: Soy

Formulation Notes

Contains: Soy

The iron in SierraSil is naturally-occurring and shown to be safe for human consumption. Research shows that only 1.1 mg of iron per serving or 6% of Daily Value is the maximum amount that is potentially bioaccessible out of the 40 mg total it contains. SierraSil cannot be used as a dietary source of iron. The suggested intake and clinical strength levels of SierraSil will not supply enough iron to satisfy RDI needs.

Additional Information

Manufactured in a GMP facility

Made in the USA

Store product in a cool and dry place.

Metadata

Product Details

UPC / SKU8 00326 50007 5
DSLD Entry Date2019-07-24
Product TypeOther Combinations
FormTablet or Pill
DSLD ID204990
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.